← Leaderboards
Andre Bessette
Eclipse Enterogenesis, Inc.
$2,640,397
Attributed
$2,640,397
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $856.7K · FY2021–25$1M$750K$500K$250K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,640,397 · 1
By mechanism
R44$2,640,397 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Length”
- Julie Ake · National Institute Of Allergy And Infectious Diseases$17,792,120
- Wendy Sammons-Jackson · National Institute Of Allergy And Infectious Diseases$17,369,420
- Andrew Shoffstall · Louis Stokes Cleveland Va Medical Center$15,790,088
- Lynn Briscoe · Leidos Biomedical Research, Inc.$10,719,410
- Tomasz Nowakowski · University Of California, San Francisco$9,024,950
- Andrea Soranno · Washington University$7,554,887
Research focus
LengthMalignant NeoplasmsFirst-In-HumanIschemic Bowel DiseaseLiver FailureAreaCurative TreatmentsExcisionIntestinal AtresiaIntestine SurgeryLifeDevicesChildChildhoodChronicAdultCrohn&AposCostGrowthInfectionIntestinal VolvulusIntestinesDistractionMechanical Device
Grant awards (4)
Outcomes study for the XL1 distraction enterogenesis device to improve nutrient absorption in short bowel syndrome patients$856,731
R44 · FY2025 · DK · contact PI
Intestinal Lengthening via Distraction Enterogenesis for the Treatment of Short Bowel Syndrome$813,592
R44 · FY2023 · DK · contact PI
Intestinal Lengthening via Distraction Enterogenesis for the Treatment of Short Bowel Syndrome$546,853
R44 · FY2022 · DK · contact PI
Intestinal Lengthening via Distraction Enterogenesis for the Treatment of Short Bowel Syndrome$423,221
R44 · FY2021 · DK · contact PI